Girl2Girl: Harnessing Text Messaging to Reduce Teenage Pregnancy Among LGB Girls
Completed · Not applicable
Conditions studied: Teenage Pregnancy
In brief
The purpose of this study is to finalize and rigorously evaluate Girl2Girl, a novel text messaging-based teenage pregnancy prevention (TPP) program designed specifically for LGB women ages 14-18 years, nation-wide. The guiding theoretical model is the Information-Motivation-Behavioral Skills (IMB) Model, which has been used extensively and is associated with increases in TPP behavior.
Key facts
- Study ID
- NCT03029962
- Run by
- Center for Innovative Public Health Research
- People needed
- 948
- Starts
- 2016-10-01
- Expected to finish
- 2020-01-12
- Last updated by the study team
- 2021-03-16
Who can join
Age: 14 and older, up to 18. Sex: female. Healthy volunteers: accepted.
You may qualify if…
- endorse a non-heterosexual sexual identity (i.e., lesbian/gay, bisexual, queer, questioning, unsure);
- be cisgender (i.e., be assigned a female sex at birth and endorse a female gender identity);
- be aged 14-18;
- in high school or equivalent (including those who did not finish school/dropped out);
- be English speaking;
- be exclusive owners of a cell phone with an unlimited text messaging plan;
- have used text messaging for at least six months;
- intend to have the same cell number for the next six months; and,
- be able to provide informed assent, including an acceptable score for "capacity to consent" and the self-safety assessment.
You may not qualify if…
- not having the capacity to assent
- not passing the self-safety assessment
- previously participating in another study activity (with the exception of the baseline and intervention end survey pilot tests)
- knowing someone who is already enrolled in the program
- non-cisgender
Where it is running
- Center for Innovative Public Health Research — San Clemente, California, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.